World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-IPR-17011152
Date of registration: 2017-04-16
Prospective Registration: No
Primary sponsor: Affiliated People's Hospital of Jiangsu University
Public title: Effect of dexmedetomidine on perioperative blood coagulation and fibrinolysis function
Scientific title: Effect of dexmedetomidine on perioperative blood coagulation and fibrinolysis function
Date of first enrolment: 2017-04-15
Target sample size: Dex group:30;Con group:30;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=18818
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  Post-market
Countries of recruitment
China
Contacts
Name: Shao Dong-Hua   
Address:  8 Dianli Road, Zhenjiang, Jiangsu, China
Telephone: +86 18952819811
Email: 13805281211@163.com
Affiliation:  Affiliated People's Hospital of Jiangsu University
Name: Zheng Chen   
Address:  8 Dianli Road, Zhenjiang, Jiangsu, China
Telephone: +86 18952819909
Email: czczgljglj@163.com
Affiliation:  Affiliated People's Hospital of Jiangsu University
Key inclusion & exclusion criteria
Inclusion criteria: ASA I or II, aged =70 year.
Exclusion criteria: BMI=28 kg/m2, preoperative coagulation disorder, abnormal platelet count, hepatic and renal insufficiency, any kind of preoperative medication that interfere with coagulation, heart disorder and preoperative blood transfusion.

Age minimum: 40
Age maximum: 70
Gender: Both
Health Condition(s) or Problem(s) studied
open radical gastrectomy
Intervention(s)
Dex group:Dexmedetomidine 0.5 ug/kg was intravenously infused over 10 minutes before anesthesia induction, followed by a rate of 0.5 ug/kg/h until peritoneal closure;Con group:Volume-matched normal saline;
Primary Outcome(s)
TEG;Standard coagulation function;The activity of plasma AT-III;The concentrations of protein C and s-TM;The concentrations of plasma PAP and t-PA and PAI;
Secondary Outcome(s)
Hematocrit and platelet count;The requirements of intraoperative propofol and remifentanil;
Secondary ID(s)
Source(s) of Monetary Support
Department of Anesthesiology, Affiliated People's Hospital of Jiangsu University
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history